I'm sorry Moreforme but T2D is one indication where we're not going to see any major announcements from MSB after the disappointing Phase 2 results. Do the research yourself and compare how MSB's modest improvements compare with other treatments and also take note of how much improvement is considered to be clinically rather than statistically significant - we were only half way there. This is why there has been no suggestion of a phase 3 for T2D only for more research regarding complications associated with it. Who knows maybe multiple regular injections would make a difference but I wouldn't be brimming with overconfidence if I were you.
MSB Price at posting:
$5.75 Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)